The Research and Development team at Ring Therapeutics is dedicated to advancing the Anellogy™ platform by conducting innovative research to harness the capabilities of the human commensal virome for gene therapy applications. This multidisciplinary team focuses on vector discovery, in vitro studies, and analytical development to translate cutting-edge scientific insights into effective therapeutic solutions, paving the way for novel treatments in genetic diseases.
View all